ask="44.10"
ask_size="100"
average_daily_volume="1024250"
bid="43.10"
bid_size="100"
book_value="4.05"
change="+2.66"
change_from_200_day_moving_average="-3.11"
change_from_50_day_moving_average="0.65"
change_from_52_week_high="-11.11"
change_From_52_week_low="12.79"
change_in_percent="+6.43%"
close="44.04"
dividend_pay_date="N/A"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-1.45"
ebitda="-134.59M"
eps_estimate_current_year="-1.68"
eps_estimate_next_quarter="-0.41"
eps_estimate_next_year="-1.76"
ex_dividend_date="N/A"
float_shares="85928000"
high="45.20"
high_52_weeks="55.15"
last_trade_date="1/6/2017"
last_trade_price="44.04"
last_trade_size="47725"
last_trade_time="4:00pm"
low="42.13"
low_52_weeks="31.25"
market_capitalization="3.83B"
moving_average_200_day="47.15"
moving_average_50_day="43.39"
name="Neurocrine Biosciences
Inc."
notes="N/A"
one_year_target_price="68.00"
open="44.00"
pe_ratio="N/A"
peg_ratio="0.68"
percent_change_from_200_day_moving_average="-6.60%"
percent_change_from_50_day_moving_average="+1.50%"
percent_change_from_52_week_high="-20.15%"
percent_change_from_52_week_low="+40.93%"
previous_close="41.38"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="10.22"
price_per_sales="239.65"
revenue="15.00M"
shares_outstanding="86871000"
short_ratio="3.97"
stock_exchange="NMS"
symbol="NBIX"
volume="3101476"
weeks_range_52="31.25 - 55.15"
